Clinical Trial Update: Active Control, Double-blind, Double-dummy, Parallel-group, Randomized Study to Assess the Effect of VECAM 40/300, Administered at Bedtime, vs. Esomeprazole 20 mg, Administered 30-60 Min. Before Dinner, on Daytime and Nighttime GERD Symptoms [Phase 2]

View source ↗

Summary

A Phase 2 randomized trial comparing VECAM 40/300 given at bedtime to esomeprazole 20 mg given before dinner, assessing daytime and nighttime GERD symptoms; the…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastroesophageal Reflux Disease

Drugs mentioned

• Esomeprazole 20 mg (esomeprazole)
• Vecam 40/300 (Vecam)

Snippet

Sponsor: Vecta Ltd. | Conditions: Gastroesophageal Reflux | Phase 2 | Status: COMPLETED